000 03566nam a22005897a 4500
008 210310s20212021 xxu||||| |||| 00| 0 eng d
022 _a1557-2625
024 _a10.3122/jabfm.2021.S1.200464 [doi]
024 _a34/Supplement/S127 [pii]
040 _aOvid MEDLINE(R)
099 _a33622827
245 _aDevelopment and Validation of the COVID-NoLab and COVID-SimpleLab Risk Scores for Prognosis in 6 US Health Systems.
251 _aJournal of the American Board of Family Medicine: JABFM. 34(Suppl):S127-S135, 2021 Feb.
252 _aJ Am Board Fam Med. 34(Suppl):S127-S135, 2021 Feb.
252 _zJ Am Board Fam Med. 34(Suppl):S127-S135, 2021 Feb.
253 _aJournal of the American Board of Family Medicine : JABFM
260 _c2021
260 _fFY2021
265 _sppublish
266 _d2021-03-10
268 _aJournal of the American Board of Family Medicine: JABFM. 34(Suppl):S127-S135, 2021 Feb.
501 _aAvailable online from MWHC library: 2001 - present
520 _aCONCLUSIONS: Because they use simple, readily available predictors, developed risk scores have potential applicability in the outpatient setting but require prospective validation before use. (c) Copyright 2021 by the American Board of Family Medicine.
520 _aMETHODS: We gathered clinical and initial laboratory variables on consecutive inpatients with COVID-19 who had either died or been discharged alive at 6 US health centers. Logistic regression was used to develop a predictive model using no laboratory values (COVID-NoLab) and one adding tests available in many outpatient settings (COVID-SimpleLab). The models were converted to point scores and their accuracy evaluated in an internal validation group.
520 _aPURPOSE: Develop and validate simple risk scores based on initial clinical data and no or minimal laboratory testing to predict mortality in hospitalized adults with COVID-19.
520 _aRESULTS: We identified 1340 adult inpatients with complete data for nonlaboratory parameters and 741 with complete data for white blood cell (WBC) count, differential, c-reactive protein (CRP), and serum creatinine. The COVID-NoLab risk score includes age, respiratory rate, and oxygen saturation and identified risk groups with 0.8%, 11.4%, and 40.4% mortality in the validation group (AUROCC = 0.803). The COVID-SimpleLab score includes age, respiratory rate, oxygen saturation, WBC, CRP, serum creatinine, and comorbid asthma and identified risk groups with 1.0%, 9.1%, and 29.3% mortality in the validation group (AUROCC = 0.833).
546 _aEnglish
650 _a*COVID-19/di [Diagnosis]
650 _a*Decision Support Systems, Clinical/st [Standards]
650 _a*Risk Assessment/mt [Methods]
650 _aAdult
650 _aAged
650 _aAged, 80 and over
650 _aCOVID-19/mo [Mortality]
650 _aFemale
650 _aHumans
650 _aMale
650 _aMiddle Aged
650 _aPandemics
650 _aPrognosis
650 _aRisk Factors
650 _aSARS-CoV-2
650 _aUnited States/ep [Epidemiology]
651 _aMedStar Washington Hospital Center
656 _aEmergency Medicine
657 _aJournal Article
700 _aGoyal, Munish
700 _aMaloy, Kevin
790 _aBarrett B, Cai X, Ebell MH, Goyal M, Krist A, Lennon R, Mainous AG 3rd, Maloy K, Tarn DM, Tuan WJ, Zgierska AE
856 _uhttps://dx.doi.org/10.3122/jabfm.2021.S1.200464
_zhttps://dx.doi.org/10.3122/jabfm.2021.S1.200464
942 _cART
_dArticle
999 _c6232
_d6232